Theurillat Group

Theurillat Group

We aim to explore the role of SPOP and CHD1 mutations to develop new therapeutic avenues for prostate cancer.

Alimonti group

Alimonti group

Our research is focused on the characterization of a novel type of cellular senescence response for cancer therapy

Catapano group

Catapano group

We investigate strategies aimed at blocking selectively transcription of genes that might be implicated in pathogenesis of cancer

Bertoni group

Bertoni group

We apply genomics techniques followed by functional studies to elucidate the lesions underlying non-Hodgkin’s lymphomas

Carbone Group

Carbone Group

We study of the molecular mechanisms that control prostate cancer development and progression

About

The lOR Institute of Oncology Research is part of the Research Division of the Oncology Institute of Southern Switzerland (IOSI), the comprehensive cancer center of the Ente Ospedaliero Cantonale (EOC), and is the main facility for basic and translational research at the IOSI. The Institute was established in 2003 formerly as the IOSI Laboratory of Experimental Oncology and is located within the Institute for Research in Biomedicine (IRB) in Bellinzona, Canton Ticino. The Institute currently employs about 50 researchers. The Institute is directed by Carlo Catapano MD, PhD and comprises different groups working in the areas of tumor biology, genomics, molecular oncology and experimental therapeutics. The expertise available in the Institute spans from cell and molecular biology to molecu...

Read More

news

IOR  Joins the Swiss Institute of Bioinformatics
12 Feb 2015

IOR Joins the Swiss Institute of Bioinformatics

With pleasure we announce that the IOR Bioinformatics Core Unit has become member of the Swiss Insti...
Steiner Cancer Research Award 2015 to Andrea Alimonti
29 Jan 2015

Steiner Cancer Research Award 2015 to Andrea Alimonti

Ricercatore IOR premiato con 1 milione Prestigioso riconoscimento con sostanzioso...
Silvia Pedrani receives Helsinn grant
10 Dec 2014

Silvia Pedrani receives Helsinn grant

IOR student Silvia Pedrani (Catapano group) receives a 2014/2015 Helsinn Advanced Synthesis student ...

Director’s foreword

Mission statement

Cancer Research